Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism
Authors:
- P.D. RaposinhoPRP.D. Raposinho
- D.D. PierrozDPD.D. Pierroz
- M.L. AubertMAM.L. Aubert
- 1 December 2001
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 185 (1-2) , 195-204
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Evidence That the Inhibition of Luteinizing Hormone Secretion Exerted by Central Administration of Neuropeptide Y (NPY) in the Rat Is Predominantly Mediated by the NPY-Y5 Receptor SubtypeEndocrinology, 1999
- Y-receptor subtypes—how many more?Trends in Neurosciences, 1997
- A receptor subtype involved in neuropeptide-Y-induced food intakeNature, 1996
- Cloning and characterization of a novel receptor to pancreatic polypeptide, a member of the neuropeptide Y receptor familyFEBS Letters, 1996
- The role of neuropeptide Y in the antiobesity action of the obese gene productNature, 1995
- Chronic Administration of Neuropeptide Y into the Lateral Ventricle Starting at 30 Days of Life Delays Sexual Maturation in the Female RatNeuroendocrinology, 1995
- Bimodal Effects of Neuropeptide Y on Hypothalamic Release of Gonadotropin-Releasing Hormone in Conscious RabbitsNeuroendocrinology, 1987
- Norepinephrine-like effects of neuropeptide Y on LH release in the ratLife Sciences, 1984
- Neuropeptide Y Distribution in the Rat BrainScience, 1983
- Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptidesNature, 1980